Medicinal composition for treating mycotic infection at superficial part and application thereof

A fungal infection and composition technology, which is applied in the field of pharmaceutical compositions for the treatment of superficial fungal infections, can solve the problems of not very good clinical curative effect, high prevalence of superficial fungal infections, and high recurrence rate

Inactive Publication Date: 2011-12-28
PEKING UNIV FIRST HOSPITAL
View PDF1 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Miconazole belongs to imidazole antifungal drugs, and is currently the main drug used for the treatment of superficial fungal infections. Bacterial infections; although widely used, the clinical efficacy is not very good, recurrent vulvovaginal candidiasis and tinea manuum are still very common superficial fungal infections
Moreover, due to the increasing numbe

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition for treating mycotic infection at superficial part and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Example 1, the killing effect of the composition of miconazole and tetrandrine on superficial fungal disease pathogens

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Concentrationaaaaaaaaaa
Login to view more

Abstract

The invention discloses a medicinal composition for treating mycotic infection at the superficial part and application thereof. The medicinal composition comprises miconazole and hanfangchin A, wherein the concentration of the hanfangchin A in a miconazole and hanfangchin A combined system is more than or equal to 40mug/ml. The medicinal composition can be used for an active component for preparing a medicament for treating the mycotic infection at the superficial part. After being verified by an in-vitro antimicrobial test, the hanfangchin A can be used for enhancing the antimycotic effect of the miconazole on dermatophyte and monilial to different degrees, in particular bacteriostasis effect on medicament-resistant fungi; and meanwhile, the dosage of the miconazole is reduced.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating superficial fungal infection and its application. Background technique [0002] Superficial fungal infection is a group of fungal infectious diseases caused by pathogenic fungi infecting human mucous membranes, skin and their appendages such as nails and hair. It is a very common fungal infectious disease in the population, and its incidence has been increasing in recent years. , Seriously affecting people's physical and mental health, quality of life and beauty needs. The incidence of superficial fungal infections has obvious population distribution characteristics. For example, tinea capitis mainly occurs in children, onychomycosis mainly occurs in the elderly or malnourished patients, tinea corporis and tinea manus and pedis mainly occur in young adults, and candida infection of the mucosa It is mainly seen in the vulva and vagina of women and the oral mucosa of immunocompromised pa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/4748A61K31/4174A61P31/10
Inventor 刘伟刘伟霞李若瑜
Owner PEKING UNIV FIRST HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products